A Survey of Urban Middle-aged Women's Sexual Function and Sexual Distress

2007 ◽  
Vol 13 (4) ◽  
pp. 254 ◽  
Author(s):  
Young-Sook Park ◽  
In Sook Cho ◽  
Yoon Mi Kim
2021 ◽  
Vol 5 (1) ◽  
pp. 01-15
Author(s):  
Hanan Elzeblawy Hassan ◽  
Ragaa Mohammed ◽  
Soad Ramadan ◽  
Hagar Masaud

Background: Sexuality is an important part of normal human functioning. Gynecological cancer and its treatments can affect one or more phases of the sexual response cycle, through alterations of sexual function. Sexual dysfunction is one of the most distressful symptoms among cervical cancer survivors. Sexual distress is a broad term encompassing any sexual discomfort and dysfunction. Sexual difficulties following cervical cancer can be stressful for couples as it can feel like a core part of the relationship has disappeared. Aim: The study is conducted to evaluate the impact of an educational program on sexual issues (sexual dysfunction & sexual distress) among cervical cancer survivors' women in Northern Upper Egypt. Methods; Design: A quasi-experimental design. Setting: out-patient clinic in the oncology unit at Beni-Suef University Hospital. Subjects: A purposive sample of 70 women. Tools: structured interviewing questionnaire sheet, female sexual function index, and female sexual distress scale. Results: The results of the study revealed regression of all items of women’s sexual distress scores, and progression of all items of women’s sexual items post-program compared to pre-one. Conclusion: The teaching program was very effective in improving sexuality among cervical cancer survivors' women. Recommendations: Disseminate the educational booklet at health centers and oncology outpatients. Integrate psychologist, psychosexual specialist, and social worker in treatment and counseling program for women with cervical cancer in the early stage of their treatment.


2018 ◽  
Vol 30 (4) ◽  
pp. 412-421 ◽  
Author(s):  
Gemma Mestre-Bach ◽  
Iris Tolosa-Sola ◽  
Ignacio Rodríguez ◽  
Pere Barri-Soldevila ◽  
Gracia Lasheras ◽  
...  

2018 ◽  
Vol 25 (11) ◽  
pp. 1244-1255 ◽  
Author(s):  
Nancy E. Avis ◽  
Xinhua Zhao ◽  
Catherine B. Johannes ◽  
Marcia Ory ◽  
Sarah Brockwell ◽  
...  
Keyword(s):  

2020 ◽  
Vol 24 (6) ◽  
pp. 2045-2055
Author(s):  
Parvin Abedi ◽  
Pourandokht Afshari ◽  
Masumeh Yaralizadeh ◽  
Maryam Dastoorpoor

2010 ◽  
Vol 38 (2) ◽  
pp. 370-377 ◽  
Author(s):  
ABDELOUAHID TAJAR ◽  
TERENCE W. O’NEILL ◽  
DAVID M. LEE ◽  
DARYL B. O’CONNOR ◽  
GIOVANNI CORONA ◽  
...  

Objective.To determine whether musculoskeletal pain was associated with impaired sexual function in a population sample of middle-aged and older men.Methods.The European Male Ageing Study (EMAS), a multicenter population-based study of men aged 40–79 years, was used to investigate this hypothesis. A questionnaire asked about the presence and duration of musculoskeletal pain, allowing subjects to be classified into 1 of 3 groups: those reporting chronic widespread pain (CWP), those reporting pain but not CWP (“some pain”), and those with no pain. Subjects completed a sexual function questionnaire from which 3 domains were considered: overall sexual functioning (OSF), sexual functioning-related distress (SFD), and change in sexual functioning compared to 1 year ago (CSF).Results.A total of 3206 men [mean age 60 (SD 11) yrs] had complete data on pain status. Of these, 8.7% had CWP and 50.34% had “some pain.” Pain was associated with lower OSF, and higher SFD and CSF scores. After adjustment for putative confounding factors, the associations became non-significant with OSF and CSF but persisted for SFD. Associations between pain status and some items within the sexual functioning domains, including frequency of sexual intercourse, frequency of morning erections, sexual desire, and orgasm were also significant, although these associations varied by pain status.Conclusion.Musculoskeletal pain is associated with several aspects of sexual functioning. These relationships differ depending on the extent of the pain (chronic or not) and are also largely confounded by other health-related factors, primarily depression.


2015 ◽  
Vol 2015 ◽  
pp. 1-9 ◽  
Author(s):  
Swati Dongre ◽  
Deepak Langade ◽  
Sauvik Bhattacharyya

Background.Many women experience sexual dysfunction where there are orgasm disorders and sexual difficulties. Ashwagandha (Withania somnifera) is a herb known to improve the body’s physical and psychological condition.Objective.The purpose of the study was to determine the efficacy and safety of a high-concentration ashwagandha root extract (HCARE) supplementation for improving sexual function in healthy females.Methods.In this pilot study, 50 study subjects were randomized to either (i) HCARE-treated group or (ii) placebo- (starch-) treated group. The subjects consumed either HCARE or placebo capsules of 300mg twice daily for 8 weeks. Sexual function was assessed using two psychometric scales, the Female Sexual Function Index (FSFI) Questionnaire and the Female Sexual Distress Scale (FSDS), and by the number of total and successful sexual encounters.Results.The analysis indicates that treatment with HCARE leads to significantly higher improvement, relative to placebo, in the FSFI Total score (p<0.001), FSFI domain score for “arousal” (p<0.001), “lubrication” (p<0.001), “orgasm” (p=0.004), and “satisfaction” (p<0.001), and also FSDS score (p<0.001) and the number of successful sexual encounters (p<0.001) at the end of the treatment.Conclusions.This study demonstrated that oral administration of HCARE may improve sexual function in healthy women. The present study is registered in the Clinical Trial Registry, Government of India, with a numberCTRI/2015/07/006045.


2013 ◽  
Vol 10 (9) ◽  
pp. 2255-2264 ◽  
Author(s):  
Els Pazmany ◽  
Sophie Bergeron ◽  
Lukas Van Oudenhove ◽  
Johan Verhaeghe ◽  
Paul Enzlin

Sign in / Sign up

Export Citation Format

Share Document